Pepscan’s VEGF targetted vaccine study published in PNAS

Evert van Dijk News releases

Researchers of Pepscan have developed a peptide-based vaccine enabling a successful active anti-tumor immunization therapy targeting the growth hormone Vascular Endothelial Growth Factor (VEGF). The encouraging preclinical results have just been published in the reputable international journal PNAS (Proceedings of the National Academy of Sciences). VEGF is the pivotal growth factor for the formation of new blood vessels (angiogenesis). Targeting VEGF is a well established strategy to treat cancer, as demonstrated by the use of the monoclonal antibody bevacuzimab (Avastin®) …

Highly successful Dutch Peptide Symposium 2016 in Lelystad

Silvia Boelens News releases

Almost 200 scientists from over 10 different countries convened on June 3 rd for the Dutch Peptide Symposium 2016, this time hosted by Pepscan in its hometown Lelystad. What originally started as an annual meeting of only Dutch scientists has now matured to an international symposium with participants form over 10 different countries. Over 20 different sponsors made this event possible through their financial support. This years’ meeting brought together scientists from academia and industry, and covered various aspects of …

Pepscan to host the 24th Dutch Peptide Symposium

Evert van Dijk News releases

As part of a tradition built by more than 20 successful Dutch Peptide Symposia, with gradually increasing numbers of participants from both academia and industry, Pepscan has the honor to host the 24th edition of the annual Dutch Peptide Symposium in 2016. We look forward to receive on 3 June, 2016 approximately 200 scientists in the novel Agora Congress Centre in Lelystad, the Netherlands. This meeting intends to cover the various aspects of peptide-, protein chemistry as well as drug discovery …

Pepscan establishes distribution partnership in Japan

Evert van Dijk News releases

Lelystad, the Netherlands – October 15, 2015:  Pepscan Presto BV, a first class provider of custom peptide products and services for the life sciences industry, today announced that is has signed distribution agreement with Cosmo Bio Co., Ltd. of Tokyo, Japan. Cosmo Bio is a leading distributor of antibodies, enzymes, cell products, tissue culture materials and protein engineering products to universities, research institutes and pharma companies in Japan. Terms of the agreement were not disclosed. The distribution agreement will help …

Pepscan launches new website

Evert van Dijk News releases

Better access to a wealth of custom peptide-based products and services Lelystad, the Netherlands – August 21, 2015: Pepscan, a leading supplier of custom peptide-based products and services to the life sciences community, today announced the launch of their redesigned website ( With a new look and intuitive structure, it is organized to provide quicker and direct access to Pepscan’s broad portfolio of peptides and value-added services, such as Precision Epitope Mapping, its Custom Peptide Synthesis services and the PepChip …

We use cookies to ensure that we give you the best experience on our website. If you would like to, you can change your cookie settings in your browser.
For more information check our privacy policy
Find out more
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Cookie Settings
Accept All Cookies